Mark Blinn Sells 1,750 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) Director Mark Blinn sold 1,750 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the transaction, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Globe Life Price Performance

Shares of NYSE GL opened at $144.10 on Thursday. The firm has a market cap of $11.47 billion, a P/E ratio of 10.23 and a beta of 0.47. The business’s 50 day moving average is $140.04 and its 200-day moving average is $138.33. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $3.14 earnings per share. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Piper Sandler reissued an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Keefe, Bruyette & Woods boosted their price target on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Wells Fargo & Company reduced their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Evercore lowered Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research note on Tuesday, January 6th. Finally, Weiss Ratings downgraded Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Seven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.00.

Institutional Trading of Globe Life

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Picton Mahoney Asset Management lifted its stake in shares of Globe Life by 69.6% in the 4th quarter. Picton Mahoney Asset Management now owns 105,476 shares of the company’s stock valued at $14,752,000 after acquiring an additional 43,283 shares during the last quarter. Illinois Municipal Retirement Fund raised its position in Globe Life by 9.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 44,887 shares of the company’s stock valued at $6,278,000 after purchasing an additional 3,769 shares during the last quarter. Janney Montgomery Scott LLC raised its position in Globe Life by 2.4% in the fourth quarter. Janney Montgomery Scott LLC now owns 15,074 shares of the company’s stock valued at $2,108,000 after purchasing an additional 359 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of Globe Life by 3.6% during the fourth quarter. Deutsche Bank AG now owns 180,921 shares of the company’s stock valued at $25,304,000 after purchasing an additional 6,346 shares in the last quarter. Finally, Fox Run Management L.L.C. grew its holdings in shares of Globe Life by 31.8% during the fourth quarter. Fox Run Management L.L.C. now owns 7,259 shares of the company’s stock worth $1,015,000 after purchasing an additional 1,750 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.